The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Stunkard, A.
* Articles by Young, L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Stunkard, A.
* Articles by Young, L.
Related Collections
* Eating Disorders
* Other Somatic Therapy

Am J Psychiatry 1996; 153:1455-1459
Copyright © 1996 by American Psychiatric Association


BRIEF REPORTS

d-fenfluramine treatment of binge eating disorder

A Stunkard, R Berkowitz, C Tanrikut, E Reiss and L Young
Department of Psychiatry, University of Pennsylvania, Philadelphia 19104-2648, USA.

OBJECTIVE: The purpose of this study was to assess the efficacy of the appetite suppressant d-fenfluramine in the treatment of binge eating disorder. METHOD: The authors conducted an 8-week double-blind, placebo- controlled clinical trial of the drug with 28 severely obese female patients meeting full criteria for binge eating disorder. The primary outcome measure was number of binges per week, as recorded in binge diaries and reviewed weekly with the principal investigators. RESULTS: Random effects linear regression analysis showed that the rate of binge eating in the d-fenfluramine group fell three times more rapidly than that in the placebo group, a result that was both clinically and statistically significant. At 4-month follow-up the binge frequency of the d-fenfluramine group had increased to pretreatment levels and no longer differed from that of the placebo group. CONCLUSIONS: d- Fenfluramine reduced the frequency of binge eating by obese women with binge eating disorder.


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
D. E. Wilfley, S. J. Crow, J. I. Hudson, J. E. Mitchell, R. I. Berkowitz, V. Blakesley, B. T. Walsh, and The Sibutramine Binge Eating Disorder Research Gro
Efficacy of Sibutramine for the Treatment of Binge Eating Disorder: A Randomized Multicenter Placebo-Controlled Double-Blind Study
Am J Psychiatry, January 1, 2008; 165(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A. L Tata and D. R Kockler
Topiramate for Binge-Eating Disorder Associated with Obesity
Ann. Pharmacother., November 1, 2006; 40(11): 1993 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. C. Appolinario, J. Bacaltchuk, R. Sichieri, A. M. Claudino, A. Godoy-Matos, C. Morgan, M. T. Zanella, and W. Coutinho
A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder
Arch Gen Psychiatry, November 1, 2003; 60(11): 1109 - 1116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. L. McElroy, L. M. Arnold, N. A. Shapira, P. E. Keck Jr., N. R. Rosenthal, M. R. Karim, M. Kamin, and J. I. Hudson
Topiramate in the Treatment of Binge Eating Disorder Associated With Obesity: A Randomized, Placebo-Controlled Trial
Am J Psychiatry, February 1, 2003; 160(2): 255 - 261.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. E. Wilfley, R. R. Welch, R. I. Stein, E. B. Spurrell, L. R. Cohen, B. E. Saelens, J. Z. Dounchis, M. A. Frank, C. V. Wiseman, and G. E. Matt
A Randomized Comparison of Group Cognitive-Behavioral Therapy and Group Interpersonal Psychotherapy for the Treatment of Overweight Individuals With Binge-Eating Disorder
Arch Gen Psychiatry, August 1, 2002; 59(8): 713 - 721.
[Abstract] [Full Text] [PDF]


Home page
The Counseling PsychologistHome page
R. I. Stein, B. E. Saelens, J. Z. Dounchis, C. M. Lewczyk, A. K. Swenson, and D. E. Wilfley
Treatment of Eating Disorders in Women
The Counseling Psychologist, September 1, 2001; 29(5): 695 - 732.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
National Task Force on the Prevention and Treatmen
Dieting and the Development of Eating Disorders in Overweight and Obese Adults
Arch Intern Med, September 25, 2000; 160(17): 2581 - 2589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. I. Hudson, S. L. McElroy, N. C. Raymond, S. Crow, P. E. Keck Jr., W. P. Carter, J. E. Mitchell, S. M. Strakowski, H. G. Pope Jr., B. S. Coleman, et al.
Fluvoxamine in the Treatment of Binge-Eating Disorder: A Multicenter Placebo-Controlled, Double-Blind Trial
Am J Psychiatry, December 1, 1998; 155(12): 1756 - 1762.
[Abstract] [Full Text]


Home page
JWatch PsychiatryHome page
d-Fenfluramine Reduces Binge Eating
Journal Watch Psychiatry, January 1, 1997; 1997(101): 1 - 1.
[Full Text]


Home page
JWatch Women's HealthHome page
Dexfenfluramine for Binge Eating in Obese Women
Journal Watch Women's Health, December 1, 1996; 1996(1201): 6 - 6.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1996 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org